Home/Filings/4/0001437749-26-001915
4//SEC Filing

BROWN MORGAN R 4

Accession 0001437749-26-001915

CIK 0001822791other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:16 PM ET

Size

5.2 KB

Accession

0001437749-26-001915

Research Summary

AI-generated summary of this filing

Updated

Clene (CLNN) CFO Morgan Brown Receives 35,000-Share Option Grant

What Happened
Morgan R. Brown, Chief Financial Officer of Clene Inc. (CLNN), received an option grant for 35,000 shares on January 22, 2026. The Form 4 reports acquisition at $0 (award/grant); the options carry an exercise price of $5.42 per share and vest immediately upon grant. This is a compensation-related option award, not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-01-22; Form 4 filed: 2026-01-23 (timely filing).
  • Transaction type/code: Award/Grant (A); reported acquisition price: $0.00 (derivative instrument).
  • Option size & terms (footnote): 35,000 options under Clene’s Amended 2020 Stock Plan, exercise price $5.42, vest immediately.
  • Shares owned after transaction: not specified in the provided excerpt—see the full Form 4 for post-transaction beneficial ownership.
  • No indication of a 10b5-1 plan, cashless exercise, tax withholding, or late filing in the supplied details.

Context
This was a standard equity compensation grant: the company issued options that give the CFO the right to buy 35,000 shares at $5.42 each in the future. Because the options vested immediately, Brown can exercise them going forward by paying the exercise price (or use any company-allowed exercise method). Such awards are common for executive compensation and do not by themselves indicate a purchase or sale of shares on the open market.

Insider Transaction Report

Form 4
Period: 2026-01-22
BROWN MORGAN R
Chief Financial Officer
Transactions
  • Award

    stock option

    [F1]
    2026-01-22+35,00035,000 total
    Exercise: $5.42Exp: 2036-01-21common stock (35,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 22, 2026 as an option for 35,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant.
Signature
/s/ Jerome T. Miraglia POA|2026-01-23

Issuer

Clene Inc.

CIK 0001822791

Entity typeother

Related Parties

1
  • filerCIK 0001266062

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:16 PM ET
Size
5.2 KB